The importance of rapid screening in the fight against the epidemic! Contipharma on the front line.
“Rapid screening is essential to prevent and control the epidemic, according to Bernard DELHEZ, CEO, who is in the Democratic Republic of the Congo this week, the epicenter of the MPOX epidemic where more than 1,000 new cases were reported last week, according to ECOFIN Africa” … The DRC has ordered one million of its rapid antigen tests for virus detection from Contipharma and announced a 49 million euro plan to counter the alarming spread of the virus.
This is a first step before the arrival of the new generation of Mpox screening tests, LAMPOX™ currently under evaluation, developed and perfected by Contipharma with the support of INRB in Kinshasa.
